Articles

Lilly announced the TRIUMPH-1 results: −28.3% body weight at 80 weeks. Here's what that figure says, what it doesn't say, and why retatrutide isn't authorised in any country in the world.

The FDA approved orforglipron in April 2026 under the brand name Foundayo. It is a daily tablet that can be taken at any time of day, with no fasting and no water restriction. It is not authorised in Spain. Here is what its trials actually show.

Novo Nordisk combined semaglutide with cagrilintide expecting 25% weight loss. It came out at 22.7%, and when it was measured head to head against tirzepatide, it lost. What the data say and where it stands today.

How to obtain Ozempic and Mounjaro legally in Spain. The legitimate routes, the risks of buying without a prescription, real prices and what to look for in a serious medical service.

Ozempic and Mounjaro side effects: what to expect, how they are managed clinically and why proper medical follow-up makes all the difference.

How much it costs to lose weight with medical treatment in Spain: a breakdown of consultations, medication, follow-up and supplementation. Comparison and prices.

What the GLP-1 hormone is, how pharmacological GLP-1 agonists work, which medicines are available in Spain (Ozempic, Wegovy, Mounjaro) and what the clinical evidence shows.

What Ozempic is, how it works, who can take it and how to obtain it legally in Spain. An up-to-date medical guide reviewed by a registered endocrinologist.

A clinical comparison of Mounjaro (tirzepatide) and Ozempic (semaglutide): mechanisms of action, effectiveness in the SURMOUNT and STEP trials, and how the right choice depends on your profile.
Online medical assessment, prescription when appropriate and 1:1 follow-up with this team.